SOMERSET, N.J., Nov. 5, 2007 (PRIME NEWSWIRE) -- Juvent Medical, Inc., an expansion stage medical device innovator with a patented Dynamic Motion Therapy(r) (``DMT’’) technology for the prevention and treatment of bone loss associated with osteoporosis, the maintenance of postural stability and the enhancement of the circulatory system, announced today that the results of a recent study using mice indicate that the Company’s DMT technology may also have future applications in helping to control obesity and diabetes. The study results have received extensive national press and media coverage.
